Cargando…
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database
Combined estrogen-progestin preparations (CEPs) are associated with thromboembolic (TE) side effects. The aim of this study was to evaluate the incidence of TE using the Japanese Adverse Drug Event Report (JADER) database. Adverse events recorded from April 2004 to November 2014 in the JADER databas...
Autores principales: | Hasegawa, Shiori, Matsui, Toshinobu, Hane, Yuuki, Abe, Junko, Hatahira, Haruna, Motooka, Yumi, Sasaoka, Sayaka, Fukuda, Akiho, Naganuma, Misa, Hirade, Kouseki, Takahashi, Yukiko, Kinosada, Yasutomi, Nakamura, Mitsuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521832/ https://www.ncbi.nlm.nih.gov/pubmed/28732067 http://dx.doi.org/10.1371/journal.pone.0182045 |
Ejemplares similares
-
Time-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug Events
por: Sasaoka, Sayaka, et al.
Publicado: (2016) -
Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system
por: Fukuda, Akiho, et al.
Publicado: (2017) -
Age-related trends in injection site reaction incidence induced by the tumor necrosis factor-α (TNF-α) inhibitors etanercept and adalimumab: the Food and Drug Administration adverse event reporting system, 2004-2015
por: Matsui, Toshinobu, et al.
Publicado: (2017) -
Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database
por: Hatahira, Haruna, et al.
Publicado: (2018) -
Adverse event profiles of solvent-based and nanoparticle
albumin-bound paclitaxel formulations using the Food and Drug Administration
Adverse Event Reporting System
por: Naganuma, Misa, et al.
Publicado: (2019)